Consensus conference on the treatment of aplastic anemia

International Journal of Hematology

Volumn 72, Issue 1, 2000, Pages 118-123

  Mizoguchi, Hideaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Bone marrow transplantation; Granulocyte colony stimulating factor; Immunosuppressive therapy

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ALLOTRANSPLANTATION; APLASTIC ANEMIA; BONE MARROW TRANSPLANTATION; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; HUMAN; METHODOLOGY; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PRACTICE GUIDELINE;

ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; PRACTICE GUIDELINES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034223446     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Camilla B, O'Reilly RJ, Sensenbrenner L, el al. Anlilhoracic duel lymphocyte globulin therapy of severe aplastic anemia. Blood. 1983;62:883-888.
2. Doney K, Martin P, Slorb R, el al. A randomized trial of antihuman thymocyte globulin versus murine monoclonal antihuman T-cell antibodies as immunosuppressive therapy for aplaslic anemia. Exp Hematol. 1985;13:520-524.
3. Bacigalupo A, Chaple M, Hows J, et al. Treatment of aplastic anaemia (AA) with antilymphocyle globulin (ALG) and melhylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol. 1993;83:145-151.
4. Frickhofen N, Kaltwasser J, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone wilh or wilhoul cyclosporine: The German Aplastic Anemia Study Group. N Engl J Med. 1991;324:1297-1304.